selected publications
-
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
The Lancet. Oncology.
2018
Academic Article
GET IT
Times cited: 197 -
A phase II study of radioimmunotherapy with intraventricular 131 I-3F8 for medulloblastoma.
Pediatric blood & cancer.
2017
Academic Article
GET IT
Times cited: 51 -
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
PloS one.
2017
Academic Article
GET IT
Times cited: 33 -
A phase I study of perifosine with temsirolimus for recurrent pediatric solid tumors.
Pediatric blood & cancer.
2016
Academic Article
GET IT
Times cited: 34 -
Evaluating the Utility of a 'N-of-1' Precision Cancer Medicine Strategy: The Case for 'Time-to-Subsequent-Disease Progression'.
Oncology.
2016
Information Resource
GET IT
Times cited: 3 -
A phase I/Ib trial targeting the Pi3k/Akt pathway using perifosine: Long-term progression-free survival of patients with resistant neuroblastoma.
International journal of cancer.
2016
Academic Article
GET IT
Times cited: 41 -
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin.
Oncotarget.
2016
Academic Article
GET IT
Times cited: 54 -
Arsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2016
Academic Article
GET IT
Times cited: 16 -
Incidence and clinical significance of ESR1 mutations in heavily pretreated metastatic breast cancer patients.
OncoTargets and therapy.
2015
Academic Article
GET IT
Times cited: 45 - Prolonged progression-free survival after consolidating second or later remissions of neuroblastoma with Anti-GD2 immunotherapy and isotretinoin: a prospective Phase II study. Oncoimmunology. 2015 Academic Article GET IT
-
Low incidence of radionecrosis in children treated with conventional radiation therapy and intrathecal radioimmunotherapy.
Journal of neuro-oncology.
2015
Academic Article
GET IT
Times cited: 25 -
When overall survival fails to confirm event-free survival, should the latter be used to set the standard of care?.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Article
GET IT
Times cited: 6 -
Initial experience with genomic profiling of heavily pretreated breast cancers.
Annals of surgical oncology.
2014
Academic Article
GET IT
Times cited: 3 -
Safety profile of long-term intraventricular access devices in pediatric patients receiving radioimmunotherapy for central nervous system malignancies.
Pediatric blood & cancer.
2014
Academic Article
GET IT
Times cited: 18 -
Key role for myeloid cells: phase II results of anti-G(D2) antibody 3F8 plus granulocyte-macrophage colony-stimulating factor for chemoresistant osteomedullary neuroblastoma.
International journal of cancer.
2014
Academic Article
GET IT
Times cited: 85 -
Striking dichotomy in outcome of MYCN-amplified neuroblastoma in the contemporary era.
Cancer.
2014
Academic Article
GET IT
Times cited: 36 -
Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014
Academic Article
GET IT
Times cited: 113 -
Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?.
Pediatric blood & cancer.
2013
Academic Article
GET IT
Times cited: 5 -
Posterior reversible encephalopathy syndrome in neuroblastoma patients receiving anti-GD2 3F8 monoclonal antibody.
Cancer.
2013
Academic Article
GET IT
Times cited: 26 - Anti-GD2 antibody 3F8 and barley-derived (1 → 3),(1 → 4)-β-D-glucan: A Phase I study in patients with chemoresistant neuroblastoma. Oncoimmunology. 2013 Academic Article GET IT
-
5-day/5-drug myeloablative outpatient regimen for resistant neuroblastoma.
Bone marrow transplantation.
2012
Academic Article
GET IT
Times cited: 3 -
Murine anti-GD2 monoclonal antibody 3F8 combined with granulocyte-macrophage colony-stimulating factor and 13-cis-retinoic acid in high-risk patients with stage 4 neuroblastoma in first remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2012
Academic Article
GET IT
Times cited: 222 -
Plerixafor plus granulocyte-colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma.
Pediatric blood & cancer.
2011
Academic Article
GET IT
Times cited: 23 -
High-dose carboplatin-irinotecan-temozolomide: treatment option for neuroblastoma resistant to topotecan.
Pediatric blood & cancer.
2011
Academic Article
GET IT
Times cited: 22 -
Successful multifold dose escalation of anti-GD2 monoclonal antibody 3F8 in patients with neuroblastoma: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2011
Academic Article
GET IT
Times cited: 51 -
Variable MR imaging appearances of focal nodular hyperplasia in pediatric cancer patients.
Pediatric radiology.
2010
Academic Article
GET IT
Times cited: 18 -
Two-compartment model of radioimmunotherapy delivered through cerebrospinal fluid.
European journal of nuclear medicine and molecular imaging.
2010
Academic Article
GET IT
Times cited: 13 -
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastoma.
European journal of cancer.
2010
Academic Article
GET IT
Times cited: 13 -
Preliminary results of a phase I trial of prophylactic ethanol-lock administration to prevent mediport catheter-related bloodstream infections.
Journal of pediatric surgery.
2010
Academic Article
GET IT
Times cited: 38 -
Hypothyroidism after 131I-monoclonal antibody treatment of neuroblastoma.
Pediatric blood & cancer.
2010
Academic Article
GET IT
Times cited: 5 -
Differential impact of high-dose cyclophosphamide, topotecan, and vincristine in clinical subsets of patients with chemoresistant neuroblastoma.
Cancer.
2010
Academic Article
GET IT
Times cited: 30 -
Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma.
International journal of radiation oncology, biology, physics.
2010
Academic Article
GET IT
Times cited: 8 -
Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma.
Journal of neuro-oncology.
2009
Academic Article
GET IT
Times cited: 203 -
Reduced risk of secondary leukemia with fewer cycles of dose-intensive induction chemotherapy in patients with neuroblastoma.
Pediatric blood & cancer.
2009
Academic Article
GET IT
Times cited: 38 -
Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
International journal of radiation oncology, biology, physics.
2009
Academic Article
GET IT
Times cited: 8 -
Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2009
Academic Article
GET IT
Times cited: 70 -
Management and outcome of stage 3 neuroblastoma.
European journal of cancer.
2008
Academic Article
GET IT
Times cited: 38 -
Brain-sparing radiotherapy for neuroblastoma skull metastases.
Pediatric blood & cancer.
2008
Academic Article
GET IT
Times cited: 8 -
Transient sialoadenitis: a complication of 131I-metaiodobenzylguanidine therapy.
Pediatric blood & cancer.
2008
Academic Article
GET IT
Times cited: 30 -
Phase I study of targeted radioimmunotherapy for leptomeningeal cancers using intra-Ommaya 131-I-3F8.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2007
Academic Article
GET IT
Times cited: 86 -
A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.
Pediatric blood & cancer.
2007
Academic Article
GET IT
Times cited: 13 -
High-dose cyclophosphamide inhibition of humoral immune response to murine monoclonal antibody 3F8 in neuroblastoma patients: broad implications for immunotherapy.
Pediatric blood & cancer.
2007
Academic Article
GET IT
Times cited: 20 -
Irinotecan plus temozolomide for relapsed or refractory neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2006
Academic Article
GET IT
Times cited: 96 -
Ototoxicity from high-dose use of platinum compounds in patients with neuroblastoma.
Cancer.
2006
Academic Article
GET IT
Times cited: 100 -
Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system.
Bone marrow transplantation.
2006
Academic Article
GET IT
Times cited: 23 -
Epidural compression in neuroblastoma: Diagnostic and therapeutic aspects.
Cancer letters.
2005
Information Resource
GET IT
Times cited: 31 -
Long-term complications in survivors of advanced stage neuroblastoma.
Pediatric blood & cancer.
2005
Academic Article
GET IT
Times cited: 124 -
Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia.
Pediatric blood & cancer.
2005
Academic Article
GET IT
Times cited: 92 -
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2004
Academic Article
GET IT
Times cited: 84 -
Treatment of neuroblastoma meningeal carcinomatosis with intrathecal application of alpha-emitting atomic nanogenerators targeting disialo-ganglioside GD2.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2004
Academic Article
GET IT
Times cited: 34 -
The impact of gross total resection on local control and survival in high-risk neuroblastoma.
Journal of pediatric surgery.
2004
Academic Article
GET IT
Times cited: 134 -
Camptothecin analogs (irinotecan or topotecan) plus high-dose cyclophosphamide as preparative regimens for antibody-based immunotherapy in resistant neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2004
Academic Article
GET IT
Times cited: 37 -
Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2004
Academic Article
GET IT
Times cited: 98 -
Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience.
Medical and pediatric oncology.
2003
Academic Article
GET IT
Times cited: 62 -
Third meeting on Novel Adjuvants Currently in or Close to Clinical Testing World Health Organization--Organisation Mondiale de la Santé, Fondation Mérieux, Annecy, France, 7-9 January 2002.
Vaccine.
2003
Conference Paper
GET IT
Times cited: 24 -
Oral topotecan for refractory and relapsed neuroblastoma: a retrospective analysis.
Journal of pediatric hematology/oncology.
2003
Academic Article
GET IT
Times cited: 24 -
Curability of recurrent disseminated disease after surgery alone for local-regional neuroblastoma using intensive chemotherapy and anti-G(D2) immunotherapy.
Journal of pediatric hematology/oncology.
2003
Academic Article
GET IT
Times cited: 19 -
Impact of metaiodobenzylguanidine scintigraphy on assessing response of high-risk neuroblastoma to dose-intensive induction chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2003
Academic Article
GET IT
Times cited: 49 -
Quantitation of GD2 synthase mRNA by real-time reverse transcriptase polymerase chain reaction: clinical utility in evaluating adjuvant therapy in neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2003
Academic Article
GET IT
Times cited: 45 -
Chronic neuroblastoma.
Cancer.
2002
Academic Article
GET IT
Times cited: 23 -
Phase II trial of the anti-G(D2) monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2001
Academic Article
GET IT
Times cited: 161 -
Monoclonal antibody-based therapy of neuroblastoma.
Hematology/oncology clinics of North America.
2001
Information Resource
GET IT
Times cited: 32 -
Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
Bone marrow transplantation.
2001
Academic Article
GET IT
Times cited: 50 -
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2001
Academic Article
GET IT
Times cited: 138 -
Hyperfractionated low-dose radiotherapy for high-risk neuroblastoma after intensive chemotherapy and surgery.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2001
Academic Article
GET IT
Times cited: 99 -
Monoclonal antibody 8H9 targets a novel cell surface antigen expressed by a wide spectrum of human solid tumors.
Cancer research.
2001
Academic Article
GET IT
Times cited: 102 -
Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Cancer.
2000
Academic Article
GET IT
Times cited: 17 -
Pilot study of topotecan and high-dose cyclophosphamide for resistant pediatric solid tumors.
Medical and pediatric oncology.
2000
Academic Article
GET IT
Times cited: 61 -
Local control with multimodality therapy for stage 4 neuroblastoma.
International journal of radiation oncology, biology, physics.
2000
Academic Article
GET IT
Times cited: 63 -
Clinically critical impact of molecular genetic studies in pediatric solid tumors.
Medical and pediatric oncology.
1999
Academic Article
GET IT
Times cited: 31 - Oral etoposide for refractory and relapsed neuroblastoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1999 Academic Article GET IT
-
Intrauterine fetal diagnosis for hematologic and other congenital disorders.
Clinics in laboratory medicine.
1999
Information Resource
GET IT
Times cited: 4 -
Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?.
Medical and pediatric oncology.
1999
Academic Article
GET IT
Times cited: 12 - Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Information Resource GET IT
- Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
-
Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
1998
Academic Article
GET IT
Times cited: 46 - High risk of leukemia after short-term dose-intensive chemotherapy in young patients with solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Academic Article GET IT
-
Pharmacokinetics and acute toxicology of intraventricular 131 I-monoclonal antibody targeting disialoganglioside in non-human primates.
Journal of neuro-oncology.
1997
Academic Article
GET IT
Times cited: 17 -
Prognostic value of TrkA protein detection by monoclonal antibody 5C3 in neuroblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
1996
Academic Article
GET IT
Times cited: 14 -
Autologous bone marrow transplantation in children with advanced neuroblastoma.
Cancer.
1995
Article
GET IT
Times cited: 1